Study says new antipsychotics less cost-effective

In an economic analysis of the Clinical Antipsychotic Trials in Intervention Effectiveness (CATIE) study, NIH researchers published in

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE